Cabaletta Bio Stock Market Value
| CABA Stock | USD 2.80 0.05 1.75% |
| Symbol | Cabaletta |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. Projected growth potential of Cabaletta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cabaletta Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Cabaletta Bio's market price often diverges from its book value, the accounting figure shown on Cabaletta's balance sheet. Smart investors calculate Cabaletta Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Cabaletta Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cabaletta Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cabaletta Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cabaletta Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cabaletta Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cabaletta Bio.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Cabaletta Bio on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Cabaletta Bio or generate 0.0% return on investment in Cabaletta Bio over 90 days. Cabaletta Bio is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T ce... More
Cabaletta Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cabaletta Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cabaletta Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.25 | |||
| Information Ratio | 0.0418 | |||
| Maximum Drawdown | 32.87 | |||
| Value At Risk | (7.17) | |||
| Potential Upside | 8.44 |
Cabaletta Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cabaletta Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cabaletta Bio's standard deviation. In reality, there are many statistical measures that can use Cabaletta Bio historical prices to predict the future Cabaletta Bio's volatility.| Risk Adjusted Performance | 0.0543 | |||
| Jensen Alpha | 0.2666 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0551 | |||
| Treynor Ratio | 0.5655 |
Cabaletta Bio February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0543 | |||
| Market Risk Adjusted Performance | 0.5755 | |||
| Mean Deviation | 4.09 | |||
| Semi Deviation | 3.87 | |||
| Downside Deviation | 4.25 | |||
| Coefficient Of Variation | 1776.71 | |||
| Standard Deviation | 5.59 | |||
| Variance | 31.26 | |||
| Information Ratio | 0.0418 | |||
| Jensen Alpha | 0.2666 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0551 | |||
| Treynor Ratio | 0.5655 | |||
| Maximum Drawdown | 32.87 | |||
| Value At Risk | (7.17) | |||
| Potential Upside | 8.44 | |||
| Downside Variance | 18.04 | |||
| Semi Variance | 14.94 | |||
| Expected Short fall | (5.50) | |||
| Skewness | 1.6 | |||
| Kurtosis | 5.2 |
Cabaletta Bio Backtested Returns
Cabaletta Bio appears to be unstable, given 3 months investment horizon. Cabaletta Bio secures Sharpe Ratio (or Efficiency) of 0.072, which signifies that the company had a 0.072 % return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Cabaletta Bio, which you can use to evaluate the volatility of the firm. Please makes use of Cabaletta Bio's risk adjusted performance of 0.0543, and Mean Deviation of 4.09 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cabaletta Bio holds a performance score of 5. The firm shows a Beta (market volatility) of 0.54, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cabaletta Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cabaletta Bio is expected to be smaller as well. Please check Cabaletta Bio's information ratio, treynor ratio, and the relationship between the downside deviation and total risk alpha , to make a quick decision on whether Cabaletta Bio's price patterns will revert.
Auto-correlation | 0.11 |
Insignificant predictability
Cabaletta Bio has insignificant predictability. Overlapping area represents the amount of predictability between Cabaletta Bio time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cabaletta Bio price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Cabaletta Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out Cabaletta Bio Correlation, Cabaletta Bio Volatility and Cabaletta Bio Performance module to complement your research on Cabaletta Bio. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Cabaletta Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.